The Biden administration will not appeal a high-profile November federal court ruling to prohibit enforcement of a 340B patient definition [...] …
Month: January 2024
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Among the many tumultuous developments affecting the 340B discount drug program in 2023, the most popular news articles in 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Maximize the effectiveness of your 340B program through consistent internal audits, ensuring both compliance and enhanced savings.
Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four hospital associations are asking a federal judge in Louisiana to throw out a suit filed by the drug industry [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Johnson & Johnson will offer refunds to 340B providers related to the purchases of four of its drugs, including [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
×
*Sign up for news summaries and alerts from 340B Report